
CCRN Stock Forecast & Price Target
CCRN Analyst Ratings
Bulls say
Cross Country Healthcare is expected to continue to face near-term challenges as the healthcare staffing industry experiences post-pandemic normalization; however, the company is well-positioned for long-term growth due to its strategic pivot towards technology-driven solutions, exemplified by the recent acquisition offer from Knox Lane. The company has experienced revenue growth even during the pandemic, demonstrating its resilience and potential for further expansion as the healthcare industry faces ongoing workforce issues. Additionally, with a strong balance sheet and the leadership of CEO Kevin Clark, who has a successful track record in both healthcare staffing and technology companies, Cross Country is poised to capitalize on increased technology adoption and potential AI innovation, potentially leading to significant upside for investors.
Bears say
Cross Country Healthcare is facing challenges in the healthcare staffing industry due to pricing pressure, performance concerns, and the recent CEO transition. The company's potential for growth through technology-based staffing and expansion into other sectors is hindered by the lack of successful execution and competition. The recent termination of the merger agreement with Aya and payment of a $20 million fee highlights potential financial struggles and market share decline. Regulatory concerns surrounding their Intellify strategy also pose potential challenges for their MSP/VMS businesses.
This aggregate rating is based on analysts' research of Cross Country Healthcare and is not a guaranteed prediction by Public.com or investment advice.
CCRN Analyst Forecast & Price Prediction
Start investing in CCRN
Order type
Buy in
Order amount
Est. shares
0 shares